Bausch Health Companies Inc.
BHC
$6.59
$0.152.25%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.83B | 2.50B | 2.77B | 2.66B | 2.50B |
| Total Other Revenue | 27.00M | 24.00M | 28.00M | 24.00M | 26.00M |
| Total Revenue | 2.85B | 2.52B | 2.80B | 2.68B | 2.53B |
| Cost of Revenue | 772.00M | 738.00M | 798.00M | 750.00M | 764.00M |
| Gross Profit | 2.08B | 1.79B | 2.00B | 1.93B | 1.77B |
| SG&A Expenses | 907.00M | 860.00M | 880.00M | 795.00M | 894.00M |
| Depreciation & Amortization | 225.00M | 241.00M | 236.00M | 253.00M | 256.00M |
| Other Operating Expenses | -- | 1.00M | -- | -- | -- |
| Total Operating Expenses | 2.08B | 2.00B | 2.08B | 1.96B | 2.07B |
| Operating Income | 775.00M | 521.00M | 721.00M | 717.00M | 457.00M |
| Income Before Tax | 348.00M | -1.35B | 56.00M | 218.00M | 140.00M |
| Income Tax Expenses | 88.00M | 77.00M | 159.00M | 37.00M | 12.00M |
| Earnings from Continuing Operations | 260.00M | -1.43B | -103.00M | 181.00M | 128.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.00M | 8.00M | -9.00M | -2.00M | 20.00M |
| Net Income | 258.00M | -1.42B | -112.00M | 179.00M | 148.00M |
| EBIT | 775.00M | 521.00M | 721.00M | 717.00M | 457.00M |
| EBITDA | 1.06B | 816.00M | 1.01B | 1.02B | 764.00M |
| EPS Basic | 0.69 | -3.82 | -0.30 | 0.48 | 0.40 |
| Normalized Basic EPS | 0.63 | 0.22 | 0.52 | 0.52 | 0.01 |
| EPS Diluted | 0.68 | -3.82 | -0.30 | 0.48 | 0.40 |
| Normalized Diluted EPS | 0.63 | 0.22 | 0.52 | 0.52 | 0.01 |
| Average Basic Shares Outstanding | 375.00M | 372.80M | 373.33M | 375.50M | 370.90M |
| Average Diluted Shares Outstanding | 378.10M | 372.80M | 373.33M | 375.50M | 373.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |